Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda
  2. Nalwoga, Angela; Marshall,Vickie; Miley,Wendell; Labo,Nazzarena; Whitby,Denise; Newton, Robert; Rochford, Rosemary
  3. Infectious Agents and Cancer. 2023, Jun 14; 18(1): 38.
  1. 2.   Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
  2. Chen, H. Y.; Hayashi, G.; Lai, O. Y.; Dilthey, A.; Kuebler, P. J.; Wong, T. V.; Martin, M. P.; Vina, M. A. F.; McVean, G.; Wabl, M.; Leslie, K. S.; Maurer, T.; Martin, J. N.; Deeks, S. G.; Carrington, M.; Bowcock, A. M.; Nixon, D. F.; Liao, W.
  3. Plos Genetics. 2012, Feb; 8(2):
  1. 3.   Majority of CD4(+) T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
  2. Josefsson, L.; King, M. S.; Makitalo, B.; Brannstrom, J.; Shao, W.; Maldarelli, F.; Kearney, M. F.; Hu, W. S.; Chen, J. B.; Gaines, H.; Mellors, J. W.; Albert, J.; Coffin, J. M.; Palmer, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11199-11204.
  1. 4.   Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
  2. Musselwhite, L. W.; Sheikh, V.; Norton, T. D.; Rupert, A.; Porter, B. O.; Penzak, S. R.; Skinner, J.; Mican, J. M.; Hadigan, C.; Sereti, I.
  3. Aids. 2011, Mar; 25(6): 787-795.
  1. 5.   Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes
  2. Niu, L. G.; Termini, J. M.; Kanagavelu, S. K.; Gupta, S.; Rolland, M. M.; Kulkarni, V.; Pavlakis, G. N.; Felber, B. K.; Mullins, J. I.; Fischl, M. A.; Stone, G. W.
  3. Vaccine. 2011, Mar; 29(11): 2110-2119.
  1. 6.   HLA/KIR Restraint of HIV: Surviving the Fittest
  2. Bashirova, A. A.; Thomas, R.; Carrington, M.; Paul, W. E.; Littman, D. R.; Yokoyama, W. M.
  3. Annual Review of Immunology. 2011 29: 295-317.
  1. 7.   Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients
  2. Hendrickson, S. L.; Jabs, D. A.; Van Natta, M.; Lewis, R. A.; Wallace, D. C.; O'Brien, S. J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2010, Apr; 53(4): 451-455.
  1. 8.   Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
  2. McMahon, D.; Jones, J.; Wiegand, A.; Gange, S. J.; Kearney, M.; Palmer, S.; McNulty, S.; Metcalf, J. A.; Acosta, E.; Rehm, C.; Coffin, J. M.; Mellors, J. W.; Maldarelli, F.
  3. Clinical Infectious Diseases. 2010, Mar; 50(6): 912-919.
  1. 9.   Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques
  2. Gordon, S. N.; Weissman, A. R.; Cecchinato, V.; Fenizia, C.; Ma, Z. M.; Lee, T. H.; Zaffiri, L.; Andresen, V.; Parks, R. W.; Jones, K. S.; Heraud, J. M.; Ferrari, M. G.; Chung, H. K.; Venzon, D.; Mahieux, R.; Murphy, E. L.; Jacobson, S.; Miller, C. J.; Ruscetti, F. W.; Franchini, G.
  3. Journal of Virology. 2010, Mar; 84(6): 3043-3058.
  1. 10.   Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
  2. Chen, L.; Kwon, Y. D.; Zhou, T. Q.; Wu, X. L.; O'Dell, S.; Cavacini, L.; Hessell, A. J.; Pancera, M.; Tang, M.; Xu, L.; Yang, Z. Y.; Zhang, M. Y.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Nabel, G. J.; Posner, M. R.; Sodroski, J.; Wyatt, R.
  3. Science. 2009 326(5956): 1123-1127.
  1. 11.   CCL3L1 and HIV/AIDS susceptibility
  2. Urban, T. J.; Weintrob, A. C.; Fellay, J.; Colombo, S.; Shianna, K. V.; Gumbs, C.; Rotger, M.; Pelak, K.; Dang, K. K.; Detels, R.; Martinson, J. J.; O'Brien, S. J.; Letvin, N. L.; McMichael, A. J.; Haynes, B. F.; Carrington, M.; Telenti, A.
  3. Nature Medicine. 2009 15(10): 1110-1112.
  1. 12.   KIR-HLA intercourse in HIV disease
  2. Carrington, M.; Martin, M. P.; van Bergen, J.
  3. Trends in Microbiology. 2008 16(12): 620-627.
  1. 13.   Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro
  2. Tilton, J. C.; Manion, M. M.; Luskin, M. R.; Johnson, A. J.; Patamwenu, A. A.; Hallahan, C. W.; Cogliano-Shutta, N. A.; Mican, J. M.; Davey, R. T.; Kottilil, S.; Lifson, J. D.; Metcalf, J. A.; Lempicki, R. A.; Connors, M.
  3. Journal of Virology. 2008 82(8): 3997-4006 ..
  1. 14.   Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction
  2. Kaufmann, D. E.; Kavanagh, D. G.; Pereyra, F.; Zaunders, J. J.; Mackey, E. W.; Miura, T.; Palmer, S.; Brockman, M.; Rathod, A.; Piechocka-Trocha, A.; Baker, B.; Zhu, B.; Le Gall, S.; Waring, M. T.; Ahern, R.; Moss, K.; Kelleher, A. D.; Coffin, J. M.; Freeman, G. J.; Rosenberg, E. S.; Walker, B. D.
  3. Nature Immunology. 2007, Nov; 8(11): 1246-1254.
  1. 15.   Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons
  2. Tilton, J. C.; Johnson, A. J.; Luskin, M. R.; Manion, M. M.; Yang, J.; Adelsberger, J. W.; Lempicki, R. A.; Hallahan, C. W.; McLaughlin, M.; Mican, J. M.; Metcalf, J. A.; Iyasere, C.; Connors, M.
  3. Journal of Virology. 2006, Dec; 80(23): 11486-11497.
  1. 16.   Local and systemic effects of intranodally injected CpG-C immunostimulatory-oligodeoxyribonucleotides in macaques
  2. Teleshova, N.; Kenney, J.; Van Nest, G.; Marshall, J.; Lifson, J. D.; Sivin, I.; Dufour, J.; Bohm, R.; Gettie, A.; Robbiani, M.
  3. Journal of Immunology. 2006, Dec; 177(12): 8531-8541.
  1. 17.   HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+T-cells
  2. Cicala, C.; Arthos, J.; Censoplano, N.; Cruz, C.; Chung, E.; Martinelli, E.; Lempicki, R. A.; Natarajan, V.; VanRyk, D.; Daucher, M.; Fauci, A. S.
  3. Virology. 2006, FEB 5; 345(1): 105-114.
  1. 18.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 19.   Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: Effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events
  2. Rhodes, T. D.; Nikolaitchik, O.; Chen, J. B.; Powell, D.; Hu, W. S.
  3. Journal of Virology. 2005, FEB; 79(3): 1666-1677.
  1. 20.   A robust measure of HIV-1 population turnover within chronically infected individuals
  2. Achaz, G.; Palmer, S.; Kearney, M.; Maldarelli, F.; Mellors, J. W.; Coffin, J. M.; Wakeley, J.
  3. Molecular Biology and Evolution. 2004, OCT; 21(10): 1902-1912.
  1. 21.   Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways
  2. Dang, Q.; Chen, J. B.; Unutmaz, D.; Coffin, J. M.; Pathak, V. K.; Powell, D.; KewalRamani, V. N.; Maldarelli, F.; Hu, W. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(2): 632-637.
  1. 22.   Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells
  2. Fonteneau, J. F.; Larsson, M.; Beignon, A. S.; McKenna, K.; Dasilva, I.; Amara, A.; Li, Y. J.; Lifson, J. D.; Littman, D. R.; Bhardwaj, N.
  3. Journal of Virology. 2004 78(10): 5223-5232.
  1. 23.   HTLV-1-encoded p30(II) is a post-transcriptional negative regulator of viral replication
  2. Nicot, C.; Dundr, M.; Johnson, J. M.; Fullen, J. R.; Alonzo, N.; Fukumoto, R.; Princler, G. L.; Derse, D.; Misteli, T.; Franchini, G.
  3. Nature Medicine. 2004 10(2): 197-201.
  1. 24.   Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo
  2. Fitzgerald, W.; Sylwester, A. W.; Grivel, J. C.; Lifson, J. D.; Margolis, L. B.
  3. Journal of Virology. 2004 78(13): 7061-7068.
  1. 25.   Peptide nucleic acids as epigenetic inhibitors of HIV-1
  2. Sei, S.
  3. Letters in Peptide Science. 2003 10(3-4): 269-286.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel